According to IMARC Group’s latest research report, titled “PEGylated Proteins Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” offers a comprehensive analysis of the industry, which comprises insights on the PEGylated proteins market trends analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 8.87% during 2024-2032.
PEGylated Proteins Market Overview:
PEGylated proteins refer to proteins that have been modified through the process of PEGylation, which involves the attachment of polyethylene glycol (PEG) molecules to the protein structure. This modification is achieved by covalently bonding PEG chains to specific sites on the protein, altering its properties and behavior. PEGylation has gained significant attention in the field of biotechnology and pharmaceuticals due to its ability to enhance the therapeutic potential of proteins. One major benefit is increased protein stability and prolonged half-life. PEGylation shields the protein from degradation and enzymatic cleavage, thereby extending its circulation time in the body. This extended half-life allows for less frequent dosing, improving patient convenience and compliance.
Get Sample Copy of Report at – https://www.imarcgroup.com/pegylated-proteins-market/requestsample
PEGylated Proteins Market Trends:
The global market is primarily driven by the increasing demand for improved therapeutic proteins with enhanced stability and extended half-life. PEGylation offers a solution by modifying proteins to enhance their resistance to degradation and enzymatic cleavage, resulting in prolonged circulation time and reduced dosing frequency. Moreover, the expanding biotechnology industry and the development of protein-based biologics also contribute to the growth of the PEGylated proteins market. PEGylation offers a means to improve the properties of protein-based therapeutics, such as monoclonal antibodies and cytokines, by enhancing their stability, solubility, and resistance to enzymatic degradation. The ability of PEGylated proteins to extend their half-life and reduce immunogenicity has led to their widespread application in the development of biologic drugs, leading to market growth and expanded therapeutic options.
Key Market Segmentation:
Competitive Landscape with Key Players:
- Abcam plc
- Biomatrik Inc.
- Creative PEGWorks
- Iris Biotech GmbH
- JenKem Technology USA Inc.
- Laysan Bio Inc.
- NOF America Corporation (NOF Corporation)
- Profacgen
- Thermo Fisher Scientific Inc.
Product Insights:
- Consumables
- PEGylation Reagents
- PEGylation Kits
- Services
Protein Type Insights:
- Colony Stimulating Factors
- Interferons
- Erythropoietin
- mAbs
- Recombinant Factor VII
- Others
Application Insights:
- Cancer Treatment
- Hepatitis
- Chronic Kidney Diseases
- Hemophilia
- Multiple Sclerosis
- Gastrointestinal Disorders
- Others
End User Insights:
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
Breakup by Region:
- North America (United States, Canada)
- Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance
- Market Outlook
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
